Sildenafil
Product Images NDC 68071-2608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2608 3)

Pdp (68071 2608 3)
This is a description of two products manufactured by NuCare Pharmaceuticals, Inc. The first one is Sidersti 20mg, with Lot: 00000 NDC: 68071-2608-03, pack size 28 tablets, manufactured by MFR NDC: 27241-124-03. The second product is Sildenafil 20mg, with Lot: 00000 NDC: 68071-2608-03, pack size 30 tablets with product number P2215030, and manufactured by MFR NDC: 27241-124-03. However, there is a WARNING instructing to keep both products out of reach of children and to store at temperatures between 68-77°F. Additionally, the patients are advised to call their doctor if experiencing any side effects or call 1-800-FDA-1088 to report any side effects to the FDA. The expiration date is not available.*
FDA Label Image

Figure1 (Sildenafil Figure 1)

Figure1 (Sildenafil Figure 1)
FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

Sildenafil_fig2 (Sildenafil Figure 2)
FDA Label Image

Figure3 (Sildenafil Figure 3)

Figure3 (Sildenafil Figure 3)
This text provides information on drug interactions involving various medications such as Acenocoumarol, Aspirin, Aorvastatin, Bosentan, Doxazosint, Doxazssing, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. The text also provides information on recommendations for dose adjustment and co-administration of these medications. Additionally, it includes data on fold change and 80% CI for various parameters such as INR AUC, INR Cmax, BT, cmax, and AUC. Overall, this text provides valuable information for healthcare professionals managing patients with these medications.*
FDA Label Image

Figure4 (Sildenafil Figure 4)

Figure4 (Sildenafil Figure 4)
FDA Label Image

Figure5 (Sildenafil Figure 5)

Figure5 (Sildenafil Figure 5)
FDA Label Image

Figure6 (Sildenafil Figure 6)

Figure6 (Sildenafil Figure 6)
FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

Sildenafil-figure-7 (Sildenafil Figure 7)
FDA Label Image

Structure (Sildenafil Structure)

Structure (Sildenafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.